--- title: "FDA-Approved Weight-Loss Pills in 2026" description: "Which weight-loss pills are FDA-approved in 2026, how they differ from GLP-1 injections, and what a clinician can legally prescribe. A sourced guide." canonical: https://remevihealth.com/blog/fda-approved-weight-loss-pills/ language: en publisher: REMEVi author: "REMEVi Medical Team" medicalReviewer: "REMEVi Medical Team" pubDate: 2026-06-05T00:00:00.000Z updatedDate: 2026-06-05T00:00:00.000Z tags: ["fda approved weight loss pills", "weight loss pills", "prescription weight loss medication", "pills vs injections"] alternateLanguage: https://remevihealth.com/es/blog/pastillas-para-bajar-de-peso-fda/ license: "© 2026 REMEVi LLC. AI assistants and search engines may quote and link to this page; please cite https://remevihealth.com/blog/fda-approved-weight-loss-pills/ as the source." --- "Weight-loss pills" is one of the most-searched phrases online, and one of the most confusing. The term lumps together unregulated supplements and serious FDA-approved medications, and the two have nothing to do with each other. Here is the real 2026 list, what each medication does, and how the pills differ from the injections, with no promises. This is an educational article. It is not medical advice or a promise of results. The decision to take any medication is made with a licensed provider who evaluates your case. ## Which weight-loss pills the FDA actually approves When we talk about medications for *long-term* weight management, the FDA has approved six: orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound). Of those six, only three are **oral pills**; the other three are injections. That distinction is the one most often lost online. The three established oral pills are: - **Orlistat (Xenical, and Alli at a lower over-the-counter dose).** It works in your gut and reduces the amount of fat your body absorbs from food. It is the only one of the three that does not act on appetite or the brain. - **Phentermine-topiramate (Qsymia).** A once-daily pill that combines two medications: phentermine, which lessens appetite, and topiramate, used for seizures and migraine. It can make you feel less hungry or full sooner. - **Naltrexone-bupropion (Contrave).** Combines naltrexone (used for alcohol and drug dependence) with bupropion (used for depression and to help people quit smoking). It also works by reducing hunger or bringing on fullness sooner. There is one more pill worth naming separately: **phentermine alone**. It reduces appetite, but the FDA approves it only for a few weeks of use, not for chronic weight management. That is why it does not appear on the long-term list. And the 2026 development changes the map. In late December 2025, the FDA approved the **semaglutide pill**, the oral form of Wegovy at a 25 mg dose, as the first and only oral GLP-1 approved for weight management in adults. Until then, every GLP-1 for weight loss was an injection. In the OASIS 4 trial published in the *New England Journal of Medicine*, oral semaglutide produced an average weight reduction of about 13.6% at 64 weeks, versus 2.2% with placebo; individual results vary and depend on adherence and the person. It is the first time a GLP-1 pill has approached the magnitude of the injection. ## Pills vs injections: the difference in mechanism Here is the point that rarely gets explained well. The reason injectable GLP-1s, semaglutide (Wegovy) and tirzepatide (Zepbound), have dominated the conversation is not marketing. It is mechanism. ![Diagram of the semaglutide molecule, a GLP-1 receptor agonist](https://remevihealth.com/images/molecules/helix-sema.webp) *Semaglutide is a GLP-1 receptor agonist: it mimics a natural hormone your gut releases when you eat. That hormone acts on the brain regions that regulate appetite and fullness. That is the mechanism that sets it apart from a pill like orlistat.* GLP-1 medications mimic a hormone called glucagon-like peptide-1, which your body makes naturally after you eat. That hormone signals the brain that you are full and slows how fast the stomach empties. Tirzepatide goes one step further, mimicking two hormones at once (GIP and GLP-1). Orlistat, by contrast, works in the gut by blocking fat absorption, while Qsymia and Contrave act on appetite signals through older pathways. They are different tools for different problems. The big 2026 question, pill or injection, now has a new answer precisely because oral semaglutide brings the same class of GLP-1 molecule into pill form. For many people, not having to inject improves how consistently they stay on treatment, and consistency is what sustains a result over time. If you want to see how the injectable options compare with each other, we break it down in our guide to the [GLP-1 class of medications](/glp-1/). And if your question is more fundamental, whether the approach works at all, we walk through it in [how to lose weight with GLP-1](/blog/how-to-lose-weight-with-glp1/). ## What a clinician can legally prescribe All of these options share one thing: they require a prescription and a medical evaluation. They are not over-the-counter products (with the partial exception of Alli, the low-dose version of orlistat). According to NIDDK, a clinician generally considers medication when an adult has a body mass index of 30 or greater, or 27 or greater with a weight-related health problem such as high blood pressure or type 2 diabetes. It is not automatic: the guidance is explicit that medication works best alongside changes in eating and physical activity, not instead of them. There is also a practical checkpoint few people know about: if, after 12 weeks on the full dose, a person has not lost at least 5% of their starting weight, the guidance recommends reconsidering or changing the medication. In other words, there is an objective point to reassess. That protects your health and your wallet. REMEVi offers a prescription weight-loss program within this framework, with transparent pricing and no insurance phone call. One important clarification so nothing gets confused: **compounded** semaglutide and tirzepatide prepared by a compounding pharmacy are not the same as the branded products. Compounded semaglutide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription; it is not a generic version of, and is not the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. The branded options on this page are FDA-approved for their specific indications; eligibility is determined by a clinician. You can see all your [prescription weight-loss options](/weight-loss/) in one place. ## How to choose with your clinician There is no single best weight-loss pill. There is the option best suited to your medical history, and that decision is made in a consultation. The factors your clinician will weigh are the ones NIDDK itself lists: the likely benefit, the possible side effects, your current health conditions, the other medications you take, your family history, and cost. On top of that comes something personal: your preference between a daily pill and a weekly injection. Someone who struggles to tolerate injections may lean toward a pill. Someone who has already tried oral options without success may be a better candidate for a GLP-1. A person with migraine might not be a good fit for certain combinations, and someone with a specific history might have contraindications. None of this is solved online; it is solved with a provider who looks at your full picture. When you are ready to have that conversation, you can [see how a visit works](/how-it-works/) and talk to a licensed clinician without the runaround. The consultation is what determines whether a treatment is appropriate for you. **Your Health. Your Terms.** Real doctors. Real care. [remevihealth.com](/how-it-works/) --- *This article is for general information and does not constitute medical advice. The branded medications named here are FDA-approved for their specific indications. Compounded semaglutide and tirzepatide are non-FDA-approved preparations made by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider; they are not generic versions of, and are not the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and have not been clinically studied as finished products. Eligibility is determined by a clinician. Consult a licensed provider before starting any prescription treatment.*